Am J Transplant, Volume 17, Suppl 3 Archives - Page 68 of 181 - ATC Abstracts

2017 American Transplant Congress
Graft-versus-Host Disease Following Deceased Donor Liver Transplant.
K. Putchakayala, S. Skorupski, S. Farhan, M. Chaffins, S. Ilias, H. Pahari, K. Collins, S. Nagai, M. Abouljoud.
Henry Ford Hospital, Detroit, MI
We reviewed our institutional experience with graft-versus-host disease (GVHD) following orthotopic liver transplantation (OLT). All OLT from 10/1/2013-10/1/2016 were reviewed. Five cases of GVHD were…
2017 American Transplant Congress
Enhanced Recovery After Surgery Pathway for Living Donor Nephrectomy Patients Decreases Length of Stay and Narcotic Utilization.
R. Forbes,¹ A. King,² T. McGrane,² D. Hale,¹ W. Sandberg,² J. Wanderer,² M. McEvoy.²
¹Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, TN; ²Anesthesiology, Vanderbilt University Medical Center, Nashville, TN
Introduction:Enhanced recovery after surgery (ERAS) protocols reduce morbidity, hospital costs, and length of hospital stay although there have been few studies in living donor nephrectomy…
2017 American Transplant Congress
Interruption of RAAS in Hypertensive Proteinuric Kidney Donors.
O. Sanchez,¹ L. Ferrara,¹ D. Berglund,¹ A. Matas,² R. Foley,¹ H. Ibrahim.¹
¹Department of Internal Medicine, U of MN, Mpls, MN; ²Department of Surgery, U of MN, Minneapolis, MN
The aim of this analysis was to assess the progression of eGFR between proteinuric hypertensive living kidney donors (HTN-LKDs) receiving ACE inhibitors (ACEinh) or angiotensin…
2017 American Transplant Congress
Prognostic Histopathologic Characteristics in Recurrent IgA Nephropathy: The Clinical Significance of Vascular Change.
S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.
Seoul National University Hospital, Seoul, Korea
Background Although recurrent IgA nephropathy (IgAN) after kidney transplantation is known to cause lgraft failure, the clinical significance of histopathologic parameters in allografts needs further…
2017 American Transplant Congress
The Incremental of Cost of Incompatible Living Donor Kidney Transplant: A National Cohort Analysis.
D. Axelrod,¹ K. Lentine,² M. Schnitzler,² H. Xiao,² X. Lou,³ B. Orandi,³ J. Garonzik Wang,³ A. Massie,³ D. Segev.³
¹Surgery, East Carolina University, Greenville, NC; ²Transplant, Saint Louis University, St. Louis, MO; ³Surgery, Johns Hopkins University, Baltimore, MD
Incompatible living donor kidney transplant (ILDKT) has been established as an effective option for patients with willing but human leukocyte antigen incompatible live donors, reducing…
2017 American Transplant Congress
Multi-Stakeholder Perspectives on the Importance of Outcomes for Trials in Kidney Transplantation: An International Best Worse Scaling Survey.
M. Howell,^1,2 N. Evangelidis,^1,2 B. Sautenet,² G. Wong,^1,2,3 J. Craig,^1,2 K. Howard,¹ A. Tong.^1,2
¹School of Public Health, University of Sydney, Sydney, Australia; ²Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, NSW, Australia; ³Centre for Transplant Research, Westmead Hospital, Sydney, NSW, Australia
To optimize the benefits of kidney transplantation, recipients and clinicians should have an agreed, shared management plan. This relies on prioritizing the same outcomes but…
2017 American Transplant Congress
Emerging Application of Active Immune Targeted Delivery in Transplantation.
M. Uehara,¹ J. Azzi,¹ B. Bahmani,^1,2 J. Cheng,³ Q. Yin,³ L. Tang,³ K. Cai,³ Q. Sun,³ M. Kwon,³ Q. Xu,² G. Brandacher,⁴ R. Abdi.¹
¹Transplantation Research Center/Renal Devision, Brigham and Women's Hospital, Boston; ²Department of Biomedical Engineering, Tufts University, Boston; ³Department of Materials Science and Engineering, University of Illinois at Urbana Champaingn, IL; ⁴Plastic and Reconstructive Surgery, Johns Hopkins Medicine, Baltimore
The homing of naïve lymphocytes to the lymph node (LN) is fundamental to the priming of alloreactive T cells. LNs possess highly restricted high endothelial…
2017 American Transplant Congress
Increasing Liver Transplant Waitlist Dropout for Hepatocellular Carcinoma with Widening Geographical Disparities: Implications for Organ Allocation.
N. Mehta, M. Sarkar, J. Dodge, R. Hirose, J. Roberts, F. Yao.
UCSF, San Francisco
Given the increasing incidence of hepatocellular carcinoma (HCC) and regional differences in liver transplant (LT) rates for HCC, we used the United Network for Organ…
2017 American Transplant Congress
Trends in the Number and Medical Urgency of Adult Heart Transplant Candidates Listed as Status 1A from 2006-2015.
W. Parker,¹ M. Churpek,¹ S. Fedson,² E. Garrity.¹
¹Pulmonary and Critical Care, University of Chicago, Chicago, IL; ²Baylor College of Medicine, Houston, TX
The wider geographic sharing of hearts in 2006 may have had unintended consequences for transplant center listing behavior. This project examines trends in the number…
2017 American Transplant Congress
Significant Allosensitisation Despite Early, within 24 Hour, Graft Nephrectomy.
G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹
¹Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom; ²Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom
Introduction: Although it is well known that allograft nephrectomy (Nx) is followed by the development of donor-specific antibodies (DSAs) even after a short transplant period,…